GENEVA, May 28 -- OLEMA PHARMACEUTICALS, INC. (780 Brannan StreetSan Francisco, California 94103) filed a patent application (PCT/US2024/056230) for "SALTS AND SOLID FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST" on Nov 15, 2024. With publication no. WO/2025/106890, the details related to the patent application was published on May 22, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MYLES, David C. (c/o Olema Pharmaceuticals, Inc.780 Brannan StreetSan Francisco, California 94103), GULLAPALLI, Rampurna Prasad (c/o Olema Pharmaceuticals, Inc.780 Brannan StreetSan Francisco, California 94103), ZHANG...